Source: Virtual Congress 2021 – Diagnosis and management of COVID-19



Rating:

Share or cite this content

Citations should be made in the following way:
C. Calabrese (Napoli (NA), Italy), A. Annunziata (Napoli (NA), Italy), M. Mollica (Napoli (NA), Italy), P. Imitazione (Napoli (NA), Italy), M. Lanza (Napoli (NA), Italy), G. Polistina (Napoli (NA), Italy), M. Flora (Napoli (NA), Italy), S. Guarino (Napoli (NA), Italy), C. Palumbo (Napoli (NA), Italy), P. Pafundi (Napoli (NA), Italy), G. Fiorentino (Napoli (NA), Italy). Effectiveness of corticosteroids on HRCT features of COVID 19 pneumonia. 455

Member's Comments

No comment yet.

Related content which might interest you: Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia Source: Eur Respir J 2011; 37: 36-41 Year: 2011 Clinical course of nonspecific interstitial pneumonia: sequential HRCT findings Source: Eur Respir J 2002; 20: Suppl. 38, 587s Year: 2002 Clinical features of chronic pulmonary aspergillosis in patients with interstitial pneumonia Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas Year: 2010 Chronic eosinophilic pneumonia (CEP): Chest radiographs and CT findings in 71 cases Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010 Long-term use of inhaled corticoids on the development of pleural effusion in community-acquired pneumonia Source: Annual Congress 2012 - Hot topics in respiratory infections Year: 2012 Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis Source: Eur Respir J, 54 (1) 1801896; 10.1183/13993003.01896-2018 Year: 2019 HRCT chest: technique and pattern of usual interstitial pneumonia Source: International Congress 2018 – Idiopathic pulmonary fibrosis diagnosis: new guidelines Year: 2018 Exacerbations and inhaled corticosteroids in bronchiectasis patients Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 Impact of inhaled corticosteroid use on outcome in COPD patients hospitalised with pneumonia Source: Annual Congress 2010 - Aetiology and outcomes of infective exacerbations of COPD Year: 2010 Role of chest ultrasonography in prognosis of community-acquired pneumonia Source: International Congress 2016 – A view into a chest and pleural pathology Year: 2016 Clinical and pulmonary thin-section CT findings in acute Klebsiella pneumoniae pneumonia Source: Annual Congress 2010 - Infection, inflammation and destruction Year: 2010 Changes in stop ventilation HRCT of chest following antibiotics in infants with pulmonary exacerbation of cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment Year: 2013 The effect of maintenance azithromycin on radiological features in patients with bronchiectasis Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 Risks of pneumonia in asthmatic patients taking inhaled corticosteroids Source: Annual Congress 2010 - Management of airway disease Year: 2010 Low-dose corticosteroid use and mortality in severe community-acquired pneumonia patients Source: Eur Respir J 2015; 45: 463-472 Year: 2015 Are corticosteroids useful in community-acquired pneumonia? Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia Year: 2006 Allergic bronchopulmonary aspergillosis complicating COPD is associated with a higher exacerbation rate and a distinct pattern on chest CT scan compared to COPD Source: International Congress 2016 – Clinical studies in asthma and immunology Year: 2016 Rapid Benralizumab effectiveness in patients with severe eosinophilic asthma and bronchiectasis Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Late Breaking Abstract - Influence of omalizumab therapy on airway remodelling assessed with high-resolution computed tomography (HRCT) in severe allergic asthma patients Source: International Congress 2018 – Biomarkers and lung function in airway disease Year: 2018 Out-patient combination therapy with inhaled corticosteroids and bronchodilators is associated with lower in-hospital mortality in pneumonia in patient with COPD Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016